ALMKT — Mauna Kea Technologies SA Share News
0.000.00%
- €18.03m
- €27.51m
- €8.22m
Brief: Mauna Kea Technologies FY Total Revenue Up At 6.8 Million Euros
Brief: Mauna Kea Technologies Announces Amendment To IPF Partners Debt Agreement
Brief: Mauna Kea Technologies Says CONTACT 2 Study Met Its Clinical Endpoints
Brief: Mauna Kea Technologies Q3 Sales Is At 1.9 Million Euros
Brief: Mauna Kea Technologies Announces Executive Leadership Transition
Brief: Mauna Kea Technologies Announces First Published Report Of Live "Tele-Cellvizio®" Utilization In Vivo
Brief: Mauna Kea Technologies Announces Positive Results On Cellvizio
Brief: Mauna Kea Technologies H1 Net Loss Widens To 6.8 Million Euros
Brief: Mauna Kea Technologies H1 Sales Down At 2.7 Million Euros
Brief: Mauna Kea Technologies Announces Positive Results In Lung Transplant Patients
Brief: Mauna Kea Technologies Obtains FDA Clearance For Applications Of Cellvizio Confocal Laser Endomicroscopy In Neurosurgery
Brief: Mauna Kea Technologies Q1 Total Sales Down At EUR 1.0 Million
Brief: Mauna Kea Cellvizio Demonstrates Superior Identification Of Patients At Risk For Esophageal Cancer
Brief: Mauna Kea Technologies Appoints Christophe Lamboeuf As Chief Financial Officer
Brief: Mauna Kea Technologies Cash Position Of EUR 20.6 Million At Jan. 31
Brief: Cellvizio Obtains Positive Assessment From The Korean NECA
Brief: Mauna Kea Technologies Says Cellvizio Receives Positive Evaluation From Korean Health Authority
Brief: Mauna Kea Technologies Q4 Revenue Falls To 1.6 Million Euros
French and Benelux stocks-Factors to watch on Dec. 19